Physician
Correa, Michael
Correa, Michael was paid $155K by Medicaid between Jan 2018 and Nov 2024, across 56 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoCORREA, MICHAEL
NEW YORK, NY 10027
NEW YORK, NY 10027
33aNPI1083765531assigned 01/12/2007
33bProvider typeInternal Medicine Physician
28Total paid$155K
24GClaims67,483
24DCodes billed56
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#1,006 of 6,049
Median peer was paid$11K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,912 | $49K | |
| 2019 | 6,031 | $29K | |
| 2020 | 6,483 | $12K | |
| 2021 | 10,048 | $14K | |
| 2022 | 12,673 | $16K | |
| 2023 | 16,858 | $24K | |
| 2024incomplete | 11,478 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 9,862 | 9,435 | $54K |
| 93000 | 29% | 4,015 | 4,011 | $45K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 1,152 | 1,078 | $16K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 9.9% | 1,627 | 1,627 | $15K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 6.3% | 1,045 | 1,041 | $10K |
| 90686 | 4.8% | 708 | 708 | $7K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.5% | 269 | 269 | $2K |
| 90658 | <1% | 318 | 318 | $905.75 | |
| 3074F | <1% | 2,580 | 2,540 | $875.00 | |
| 3079F | <1% | 969 | 957 | $752.50 | |
| 99397 | <1% | 297 | 297 | $726.65 | |
| 3078F | <1% | 2,365 | 2,334 | $672.50 |
44 more codes
| 3075F | <1% | 642 | $447.50 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,942 | $223.69 |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | <1% | 117 | $203.57 |
| G0008 | Administration of influenza virus vaccine | <1% | 203 | $124.19 |
| Q2036 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | <1% | 50 | $58.34 |
| 1160F | <1% | 3,633 | $40.00 | |
| 3077F | <1% | 114 | $35.00 | |
| 1125F | <1% | 1,076 | $25.00 | |
| G9507 | Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) | 0% | 711 | $0.00 |
| 0521F | 0% | 885 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 3,890 | $0.00 |
| 1159F | 0% | 3,082 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 302 | $0.00 |
| 3288F | 0% | 200 | $0.00 | |
| 4120F | 0% | 153 | $0.00 | |
| 4013F | 0% | 1,358 | $0.00 | |
| 3725F | 0% | 372 | $0.00 | |
| 3051F | 0% | 51 | $0.00 | |
| 3046F | 0% | 42 | $0.00 | |
| 3050F | 0% | 24 | $0.00 | |
| 4025F | 0% | 12 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 27 | $0.00 |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 13 | $0.00 |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 13 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 729 | $0.00 |
| 1000F | 0% | 916 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 4,607 | $0.00 |
| 3044F | 0% | 458 | $0.00 | |
| 4016F | 0% | 576 | $0.00 | |
| 1036F | 0% | 731 | $0.00 | |
| 3008F | 0% | 8,401 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 222 | $0.00 |
| 4015F | 0% | 484 | $0.00 | |
| 3048F | 0% | 125 | $0.00 | |
| G8432 | Depression screening not documented, reason not given | 0% | 429 | $0.00 |
| H0001 | Alcohol and/or drug assessment | 0% | 74 | $0.00 |
| G8473 | Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed | 0% | 75 | $0.00 |
| 3049F | 0% | 53 | $0.00 | |
| 3351F | 0% | 132 | $0.00 | |
| 3080F | 0% | 52 | $0.00 | |
| 3014F | 0% | 12 | $0.00 | |
| 99429 | 0% | 216 | $0.00 | |
| 4010F | 0% | 48 | $0.00 | |
| 99386 | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.